|
(3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Suppliers list
|
|
| | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Basic information |
| Product Name: | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid | | Synonyms: | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid;3α-hydroxy pravastatin;3-α-hydroxy Pravastatin-D9;1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-β,δ,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, (βR,δR,1S,2R,3S,8S,8aR)-;Pravastatin Impurity 59;sodium (3R,5R)-3,5-dihydroxy-7-((1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl)heptanoate | | CAS: | 81131-74-0 | | MF: | C23H36O7 | | MW: | 424.53 | | EINECS: | | | Product Categories: | | | Mol File: | 81131-74-0.mol | ![(3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Structure](CAS/20180808/GIF/81131-74-0.gif) |
| | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Chemical Properties |
| Boiling point | 640.3±55.0 °C(Predicted) | | density | 1.21±0.1 g/cm3(Predicted) | | pka | 4.31±0.10(Predicted) |
| | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Usage And Synthesis |
| | (3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutano yl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid Preparation Products And Raw materials |
|